@darkpoolpulse.bsky.social
📊 Tracking the real moves behind the markets. 🌊 Dark pool data, fund insights, ETF strategies. 🔍 Data-driven clarity for smarter investing.
@urnov.bsky.social
Clinic-minded genome + epigenome editor. Professor of Molecular Therapeutics, UC Berkeley. Director for Technology and Translation, Innovative Genomics Institute, ibid. Beatles fan. Art work credit: Fyodor Vasiliev "A Meadow in the Rain" (1872).
@callumlaing.bsky.social
I help ambitious people raise capital, get board seats, take companies public. Bluesky Capitalist... Author of 4 best selling business books
@johnhtran.bsky.social
I track collapse in real time— and post what replaces it. Most are still reacting. Some of us are already building.
@biopharmcatalyst.bsky.social
FDA catalyst calendar, newsletters, and more. We do not provide investment advice or recommendations. #biotech #stocks https://www.biopharmcatalyst.com/
@drrichjlaw.bsky.social
Chief Business Officer of Haya Therapeutics! (formerly Exscientia/Recursion CBO), computational chemist by training (Oxford, UCSD, LLNL & Evotec), bike racer, ex-Oxford rower & LFC fan! #YNWA.
@biotechtv.bsky.social
News, stories, and educational videos about the biotechnology sector. Bringing biotech to life. 📺
@scottsinvesting.bsky.social
A day & hopefully a dollar closer to "critical mass". I'm here to talk about stocks... I'm a believer that the smartest trades are almost always based on the value you're buying or the irrational excess you're selling... Why? Valuation always matters!!
@galenlittle.bsky.social
@bsky.app
official Bluesky account (check username👆) Bugs, feature requests, feedback: support@bsky.app